AstraZeneca Pharma India has received import and market permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India.

NHPC Limited has signed a Memorandum of Understanding (MoU) with Government of Himachal Pradesh for execution of 449 MW Dugar HE Project located in Chamba District, Himachal Pradesh.

Overall volumes in futures & options currently stand at 2,30,48,515 contracts with a turnover of Rs. 15,70,828.38 crore.

Overall volumes in futures & options currently stand at 2,30,48,515 contracts with a turnover of Rs. 15,70,828.38 crore.

We would recommend traders to closely monitor price action of Nifty around Monday’s gap area. Also, today being the current month’s future and option expiry day, brace yourself for volatility. Stocks in news: SRF, Indiabulls Real Estate, Astrazeneca Pharma, Glaxosmithkline Pharmaceuticals, Cipla and NLC India.

The outlook for the day is a flat start with a positive bias and the key catalyst this morning which could boost market participants’ sentiments is the comment from US President Donald Trump that the deal with China could come sooner than expected. At the time of writing, the SGX Nifty was trading up by 20 points at 11,495 levels. However, as the session progresses, we expect volatility to kick in on account of future and option expiry for the September series. 

Tata Power Delhi Distribution (TPDDL), a joint venture between Tata Power and the Government of NCT of Delhi, has signed a memorandum of understanding (MoU) with Havells India.

Traders remained cautious as the Asian Development Bank (ADB) lowered India's Gross Domestic Product (GDP) growth forecast to 6.5 percent for the current fiscal (FY20), considering the GDP growth slipping to a six-year low in the April-June quarter of 2019-20.

While considering financial rules of thumb, prefer a simpler one that is easier to follow. What’s important is - make such rule and stick to it. It will help you to sort your finance for long term.

The stocks to watch out on September 26 include Adani Enterprises, Subex, T. T., Infosys, Sterlite Technologies and Astrazeneca Pharma.